One Stop Solution For In-Depth Market Research Reports

詳細な市場調査レポートのワンストップソリューション

Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Middle-East and Africa Self-monitoring Blood Glucose Devices Market

[ 英語タイトル ] Middle-East and Africa Self-monitoring Blood Glucose Devices Market - Growth, Trends, and Forecasts (2020 - 2025)


Product Code : MDHC0087999
Survey : Mordor Intelligence
Publish On : November, 2020
Number of Pages : 80
Category : Healthcare and Pharmaceuticals
Report format : PDF
Sales price option (consumption tax not included)
Single User USD3750 / Question Form
5 User USD4250 / Question Form
Enterprise User USD7000 / Question Form
 - Abbott
- F. Hoffmann-La Roche AG
- Platinum Equity (lifeScan)
- Arkray
- Ascensia
- Agamatrix Inc.
- Medisana
- Trivida
- I-SENS

[Report Description]

The Middle-East and Africa self-monitoring blood glucose devices market is poised to grow at a CAGR of more than 7% during the forecasting period. The self-monitoring blood glucose devices (SMBG) market is witnessing a considerable growth rate as a direct result of increasing the diabetic population in the Middle-East and Africa, due to poor lifestyle choices. The growing type-1 population also contributes to the growth of the market. Type-1 diabetic patients are recommended to test their blood glucose at least three times per day, which helps in planning insulin administration by the patient. Additionally, these devices help in the early detection of hypo and hyperglycemic conditions, which tend to drive the market for glucose monitoring. The blood glucose meter displays the results within seconds and records the data.

Key Market Trends

Test Strips Held the Highest Market Share in 2019

In the Middle-East and Africa self-monitoring blood glucose devices market, test strips held the highest share with 0.1 billion revenue in 2019. Price is often a significant concern for the purchase of blood glucose test strips. Although various countries provide reimbursements for prescribed test strips, a majority of the patients have to pay for them from their pockets. The frequency of monitoring glucose levels depends on the type of diabetes and varies from patient to patient. Type 1 diabetic patients need to check their blood glucose levels at regular intervals to adjust the insulin dosing accordingly. Therefore, if a patient performs 5-6 tests in a day, the average expenditure on test strips would be over USD 180/month. These expenses add to the already high diabetes management costs and are impeding market growth.

Saudi Arabia and Iran held more than 60% share in the Middle-East and Africa Self-monitoring Blood Glucose Market in 2019

The leading market in the Middle-East and Africa Self-monitoring blood glucose market is Saudi Arabia with 41% market share followed by Iran and others. The high sales of the devices in Saudi Arabia is due to the growing prevalence of diabetes in the country. In 2019, Saudi Arabia is having a 4.9 million diabetes population and Iran is having a 5.3 million diabetes population in which more than10% are the type-1 diabetes patients. Middle-East countries have high diabetes prevalence like Saudi Arabia 24%, Kuwait 23%, Bahrain 22%, Qatar 20%, and UAE 19%. Price is often a significant concern for the purchase of glucometers. Although Saudi Arabia, Iran, and other countries in the Middle-East and Africa region provide reimbursements for prescribed test strips, the majority of the patients have to pay for them from their pockets.

Competitive Landscape

The self-monitoring blood glucose devices market is fragmented with few major manufacturers boasting their global market presence, while the remaining manufacturers are confined to other local regions. Mergers and acquisitions that happened between the players in the recent past helped the companies to strengthen their market presence. For example, Ascensia Diabetes Care and Glooko have entered into a partnership to sync data from Ascensia blood glucose meters to Glooko’s versatile monitoring platform. ALRT Diabetes Solution in the Middle East and North Africa provides an affordable and easy to use communication network between the patient and the diabetes health care team. Health care providers have access to timely patient blood sugar information uploaded by the patients themselves. Patients and healthcare providers can send and receive messages through the system.

Reasons to Purchase this report:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support

1 INTRODUCTION
1.1 Study Assumptions
1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.3 Market Restraints
4.4 Porter's Five Forces Analysis
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Consumers
4.4.3 Threat of New Entrants
4.4.4 Threat of Substitute Products and Services
4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION
5.1 Self-monitoring Blood Glucose Devices
5.1.1 By Component (Value and Volume, 2012-2025)
5.1.1.1 Glucometer Devices
5.1.1.2 Test Strips
5.1.1.3 Lancets
5.2 By Geography
5.2.1 Middle-East and Africa
5.2.1.1 Egypt (Value and Volume, 2012-2025)
5.2.1.1.1 By Component (Glucometer Device, Test Strips, and Lancets)
5.2.1.2 Iran (Value and Volume, 2012-2025)
5.2.1.2.1 By Component (Glucometer Device, Test Strips, and Lancets)
5.2.1.3 Saudi Arabia (Value and Volume, 2012-2025)
5.2.1.3.1 By Component (Glucometer Device, Test Strips, and Lancets)
5.2.1.4 Oman (Value and Volume, 2012-2025)
5.2.1.4.1 By Component (Glucometer Device, Test Strips, and Lancets)
5.2.1.5 South Africa (Value and Volume, 2012-2025)
5.2.1.5.1 By Component (Glucometer Device, Test Strips, and Lancets)
5.2.1.6 Rest of Middle-East and Africa (Value and Volume, 2012-2025)
5.2.1.6.1 By Component (Glucometer Device, Test Strips, and Lancets)

6 MARKET INDICATORS
6.1 Type-1 Diabetes population (2012-2025)
6.2 Type-2 Diabetes population (2012-2025)

7 COMPETITIVE LANDSCAPE
7.1 Company Profiles
7.1.1 Abbott
7.1.2 F. Hoffmann-La Roche AG
7.1.3 Platinum Equity (lifeScan)
7.1.4 Arkray
7.1.5 Ascensia
7.1.6 Agamatrix Inc.
7.1.7 Medisana
7.1.8 Trivida
7.1.9 I-SENS

8 MARKET OPPORTUNITIES AND FUTURE TRENDS

渋谷データカウント

渋谷データカウントは、最も信頼性が高く最新の調査分析レポートを確実に提供する経験豊富な調査専門家のグローバルチームが提供する、さまざまな業界のさまざまな市場調査レポートを提供する再販代理店です。

Recommended reports

+